Hansen Medical is a developer and manufacturer of flexible robotic technology built for multi-specialty, peripheral vascular robotics procedures.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/28/2018 | Series D-1 | $220.42MM | $xx.xx | $213.26B | D1 Capital Partners, Lux Capital, Mithril Capital Management, Partner Fund Management, Senator Investment Group, Viking Global Investors, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
1,049,120,408
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
D1 Capital Partners, Lux Capital, Mithril Capital Management, Partner Fund Management, Senator Investment Group, Viking Global Investors, Wellington Management
|
||||||
08/04/2017 | Series D | $280.2MM | $xx.xx | $124.57B | Coatue Management, Highland Capital, Lux Capital, Mithril Capital Management, Partner Fund Management, Section 32, Viking Global Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,796,153,846
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Coatue Management, Highland Capital, Lux Capital, Mithril Capital Management, Partner Fund Management, Section 32, Viking Global Investors
|
||||||
08/09/2016 | Series C | $198.58MM | $xx.xx | $60.08B | Korea Investment Partners, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,738,911,252
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Korea Investment Partners, Undisclosed Investors
|
||||||
03/31/2014 | Series B | $33MM | $xx.xx | $6.39B | Highland Capital Partners, Lux Capital, Mithril Capital Management, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,709,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Highland Capital Partners, Lux Capital, Mithril Capital Management, Undisclosed Investors
|
||||||
08/08/2012 | Series A-2 | $1.38MM | $xx.xx | $1.65B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
148,106,471
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/02/2012 | Series A-1 | $3MM | $xx.xx | $2.46B | Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap | |
Price per Share
$xx.xx
Shares Outstanding
294,117,647
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap
|
||||||
12/22/2011 | Series A | $1.64MM | $xx.xx | $947.56MM | Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap | |
Price per Share
$xx.xx
Shares Outstanding
176,795,153
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap
|